Ophthalmology

Ophthalmology Experts & Viewpoints

Measuring Structure and Function in Patients with Glaucoma Does structural damage precede or follow visual field loss? Or do they co-occur? Drs. George Cioffi and Paul Mackenzie explore this pressing issue in the management of glaucoma.
Expert Column, June 2008
Glaucoma Medications and Ocular Surface Disease: An Expert Interview with Dr. Douglas Rhee In this expert interview from ARVO 2008, Dr. Douglas Rhee discusses the potential association between the preservatives used in glaucoma medications and ocular surface disease.
Expert Interview, May 2008
Visual Loss and Glaucoma Does trabeculectomy contribute to visual field loss in patients with glaucoma?
Commentary, October 2007
Laser-Induced Ocular Injury Laser safety is a frequently neglected prerequisite to responsible laser-based therapy.
Commentary, April 2007
The Marketplace Can't Give Us the Drug Safety Data We Need Jerry Avorn, MD, Professor of Medicine at Harvard University, explains why a more robust FDA is needed to rectify the current marketplace-based system of drug evaluation.
Editorial, February 2007
Humanitarianism -- A Whole-Cloth Profession Karen Hein, MD, Professor of Epidemiology & Population Health and Clinical Pediatrics at the Albert Einstein College of Medicine, discusses behaving in a humanitarian way.
Editorial, February 2007
Guidelines and Rules: Friend or Foe? Jonathan Adler, MD, of Massachusetts General and eMedicine, describes the central necessity of using guidelines next.
Editorial, January 2007
Hemangiomas and Ocular Problems Although benign in nature, hemangiomas in certain locations can impede vital functions.
Commentary, January 2007
Editorial: The Learning Curve This editorial introduces The Learning Curve's new editor, Steven Gelber, as he welcomes medical students, residents, physicians, healthcare professionals, and interested readers to the eSection.
Editorial, October 2006
Anti-VEGF Agent Approved for AMD: An Expert Interview With Dr. Jeffrey Heier With the FDA approval of ranibizumab, retinal specialists have a new option for AMD. Dr. Jeffrey Heier discusses the practical applications of this new drug.
Expert Interview, August 2006

More Experts & Viewpoints

Featured Viewpoint

Measuring Structure and Function in Patients with Glaucoma Does structural damage precede or follow visual field loss? Or do they co-occur? Drs. George Cioffi and Paul Mackenzie explore this pressing issue in the management of glaucoma.
Expert Column, June 2008

CLOSE [X]
SPECIALTY SITES Allergy & Clinical Immunology Cardiology Critical Care Dermatology Diabetes & Endocrinology Emergency Medicine Family Medicine Gastroenterology General Surgery Hematology-Oncology HIV/AIDS Infectious Diseases	Internal Medicine Lab Medicine Nephrology Neurology & Neurosurgery Ob/Gyn & Women's Health Oncology Ophthalmology Orthopaedics Pathology & Lab Medicine Pediatrics Psychiatry & Mental Health Public Health & Prevention Pulmonary Medicine	Radiology Rheumatology Surgery Transplantation Urology Women's Health OTHER SITES Business of Medicine Medscape Today Med Students Nurses Pharmacists

CLOSE [X]
SPECIALTY SITES Allergy & Clinical Immunology Cardiology Critical Care Dermatology Diabetes & Endocrinology Emergency Medicine Family Medicine Gastroenterology General Surgery Hematology-Oncology HIV/AIDS Infectious Diseases	Internal Medicine Lab Medicine Nephrology Neurology & Neurosurgery Ob/Gyn & Women's Health Oncology Ophthalmology Orthopaedics Pathology & Lab Medicine Pediatrics Psychiatry & Mental Health Public Health & Prevention Pulmonary Medicine	Radiology Rheumatology Surgery Transplantation Urology Women's Health OTHER SITES Business of Medicine Medscape Today Med Students Nurses Pharmacists